Skip to main content
Log in

Absolute bioavailability of theophylline from a sustained-release formulation using different intravenous reference infusions

  • Short Communications
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

The effect of different intravenous infusions on the absolute bioavailability of theophylline from a sustained-release formulation has been investigated. Oral administration of 750 mg theophylline (2 capsules Euphylong 375) was referenced to intravenous aminophylline infusions corresponding to 506 mg theophylline over 8 h (63 mg·h−1) in Study 1, and to 749 mg theophylline over 14 h in Study 2. A reduction in the infusion rate from 69 to 33 mg·h−1 was made in Study 2 after 8 h in order to mimic the concentration/time profile of the oral formulation as closely as possible. The absolute bioavailability was 100 (89, 115) % in Study 1 and 88 (73, 105) % in Study 2.

The lower clearance values and, as a consequence, the lower bioavailability ratios observed with the higher intravenous dose, although not significant, indicate that the absolute bioavailability of theophylline might appear to depend on the choice of the intravenous reference standard.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Anonymous (1985) Entwurf der APV-Richtlinie: Untersuchungen zur Bioverfügbarkeit, Durchführung und Beurteilung. Pharm Ind 47: 1016–1019

  2. Dengler HJ, Beuckelmann I, Tuerk A, Vögele D (1981) Die mittlere Verweildauer — Ein Maß zur Bewertung der Bioverfügbarkeit eines retardierten Theophyllin-Präparates. In: Rietbrock N, Woodcock BG, Staib AH (eds) Theophylline and other methylxanthines. Proceedings of an International Symposium, Frankfurt/Main 29th and 30th May 1981. Vieweg, Braunschweig, FRG, pp 83–90

    Google Scholar 

  3. Flühler H, Grieve AP, Mandallaz D, Mau J, Moser HA (1983) Bayesian approach to bioequivalence assessment: An example. J Pharm Sci 72: 1178–1181

    Google Scholar 

  4. Greenblatt H, Duhme DW, Koch-Weser J, Smith TW (1974) Intravenous digoxin as bioavailability standard: Slow infusion and rapid injection. Clin Pharmacol Ther 15: 510–513

    Google Scholar 

  5. Gundert-Remy U, Hildebrandt R, Hengen N, Weber E (1983) Non-linear elimination processes of theophylline. Eur J Clin Pharmacol 24: 71–78

    Google Scholar 

  6. Jonkman JH, Tang D, Upton RA, Riegelman S (1981) Measurement of excretion characteristics of theophylline and its major metabolites. Eur J Clin Pharmacol 20: 435–441

    Google Scholar 

  7. Riegelman S, Collier P (1980) The application of statistical moment theory to the evaluation of in vivo dissolution time and absorption time. J Pharmacokinet Biopharm 8: 509–534

    Google Scholar 

  8. Schulz HU, Steinijans VW, Gabel H (1984) Differences in steady-state plasma levels between aminophylline and theophylline sustained-release micropellets after repeated circadian dosing. Int J Clin Pharmacol Ther Toxicol 22: 621–625

    Google Scholar 

  9. Steinijans VW, Diletti E (1983) Statistical analysis of bioavailability studies: Parametric and nonparametric confidence intervals. Eur J Clin Pharmacol 24: 127–136

    Google Scholar 

  10. Steinijans VW, Schulz HU, Beier W, Radtke HW (1986) Once daily theophylline: Multiple-dose comparison of an encapsulated micro-osmotic system (Euphylong) with a tablet (Uniphyllin). Int J Clin Pharmacol Ther Toxicol 24: 438–447

    Google Scholar 

  11. Tang-Liu DD, Williams RL, Riegelman S (1982) Nonlinear theophylline elimination. Clin Pharmacol Ther 31: 358–369

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Steinijans, V.W., Schulz, H.U., Böhm, A. et al. Absolute bioavailability of theophylline from a sustained-release formulation using different intravenous reference infusions. Eur J Clin Pharmacol 33, 523–526 (1987). https://doi.org/10.1007/BF00544248

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00544248

Key words

Navigation